These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

386 related items for PubMed ID: 17023492

  • 1. A prospective multicentre study of the role of anaemia as a risk factor in haemodialysis patients: the MAR Study.
    Portolés J, López-Gómez JM, Aljama P.
    Nephrol Dial Transplant; 2007 Feb; 22(2):500-7. PubMed ID: 17023492
    [Abstract] [Full Text] [Related]

  • 2. [Cardiovascular risk in hemodialysis in Spain: prevalence, management and target results (MAR study)].
    Portolés J, López-Gómez JM, Aljama P.
    Nefrologia; 2005 Feb; 25(3):297-306. PubMed ID: 16053011
    [Abstract] [Full Text] [Related]

  • 3. The impact of new onset anaemia on morbidity and mortality in chronic heart failure: results from COMET.
    Komajda M, Anker SD, Charlesworth A, Okonko D, Metra M, Di Lenarda A, Remme W, Moullet C, Swedberg K, Cleland JG, Poole-Wilson PA.
    Eur Heart J; 2006 Jun; 27(12):1440-6. PubMed ID: 16717081
    [Abstract] [Full Text] [Related]

  • 4. Anemia management and treatment response in patients on hemodialysis: the MAR study.
    Portolés J, López-Gómez JM, Aljama P.
    J Nephrol; 2006 Jun; 19(3):352-60. PubMed ID: 16874697
    [Abstract] [Full Text] [Related]

  • 5. Prevalence, incidence, and prognostic value of anaemia in patients after an acute myocardial infarction: data from the OPTIMAAL trial.
    Anker SD, Voors A, Okonko D, Clark AL, James MK, von Haehling S, Kjekshus J, Ponikowski P, Dickstein K, OPTIMAAL Investigators.
    Eur Heart J; 2009 Jun; 30(11):1331-9. PubMed ID: 19383732
    [Abstract] [Full Text] [Related]

  • 6. Haemoglobin level and vascular access survival in haemodialysis patients.
    Garrancho JM, Kirchgessner J, Arranz M, Klinkner G, Rentero R, Ayala JA, Marcelli D.
    Nephrol Dial Transplant; 2005 Nov; 20(11):2453-7. PubMed ID: 16077146
    [Abstract] [Full Text] [Related]

  • 7. Hemoglobin level, chronic kidney disease, and the risks of death and hospitalization in adults with chronic heart failure: the Anemia in Chronic Heart Failure: Outcomes and Resource Utilization (ANCHOR) Study.
    Go AS, Yang J, Ackerson LM, Lepper K, Robbins S, Massie BM, Shlipak MG.
    Circulation; 2006 Jun 13; 113(23):2713-23. PubMed ID: 16754803
    [Abstract] [Full Text] [Related]

  • 8. Anaemia and mortality in haemodialysis patients: interaction of propensity score for predicted anaemia and actual haemoglobin levels.
    Roberts TL, Foley RN, Weinhandl ED, Gilbertson DT, Collins AJ.
    Nephrol Dial Transplant; 2006 Jun 13; 21(6):1652-62. PubMed ID: 16449283
    [Abstract] [Full Text] [Related]

  • 9. [Late nephrology referral influences on morbidity and mortality of hemodialysis patients. A provincial study].
    Peña JM, Logroño JM, Pernaute R, Laviades C, Virto R, Vicente de Vera C.
    Nefrologia; 2006 Jun 13; 26(1):84-97. PubMed ID: 16649429
    [Abstract] [Full Text] [Related]

  • 10. Anemia and hypoalbuminemia at initiation of hemodialysis as risk factor for survival of dialysis patients.
    Anees M, Ibrahim M.
    J Coll Physicians Surg Pak; 2009 Dec 13; 19(12):776-80. PubMed ID: 20042156
    [Abstract] [Full Text] [Related]

  • 11. Mineral metabolism and cardiovascular morbidity and mortality risk: peritoneal dialysis patients compared with haemodialysis patients.
    Noordzij M, Korevaar JC, Bos WJ, Boeschoten EW, Dekker FW, Bossuyt PM, Krediet RT.
    Nephrol Dial Transplant; 2006 Sep 13; 21(9):2513-20. PubMed ID: 16799173
    [Abstract] [Full Text] [Related]

  • 12. Mineral metabolism and haemoglobin concentration among haemodialysis patients in the Dialysis Outcomes and Practice Patterns Study (DOPPS).
    Kimata N, Akiba T, Pisoni RL, Albert JM, Satayathum S, Cruz JM, Akizawa T, Andreucci VE, Young EW, Port FK.
    Nephrol Dial Transplant; 2005 May 13; 20(5):927-35. PubMed ID: 15728270
    [Abstract] [Full Text] [Related]

  • 13. Mortality in incident haemodialysis patients: time-dependent haemoglobin levels and erythropoiesis-stimulating agent dose are independent predictive factors in the ANSWER study.
    Fort J, Cuevas X, García F, Pérez-García R, Lladós F, Lozano J, Martín-Malo A, ANSWER study.
    Nephrol Dial Transplant; 2010 Aug 13; 25(8):2702-10. PubMed ID: 20176608
    [Abstract] [Full Text] [Related]

  • 14. Prediction of time-averaged concentration of haemoglobin in haemodialysis patients.
    Krisper P, Quehenberger F, Schneditz D, Holzer H, Polaschegg HD.
    Nephrol Dial Transplant; 2003 Oct 13; 18(10):2082-7. PubMed ID: 13679484
    [Abstract] [Full Text] [Related]

  • 15. Associates of mortality and hospitalization in hemodialysis: potentially actionable laboratory variables and vascular access.
    Lacson E, Wang W, Hakim RM, Teng M, Lazarus JM.
    Am J Kidney Dis; 2009 Jan 13; 53(1):79-90. PubMed ID: 18930570
    [Abstract] [Full Text] [Related]

  • 16. Association of mortality and hospitalization with achievement of adult hemoglobin targets in adolescents maintained on hemodialysis.
    Amaral S, Hwang W, Fivush B, Neu A, Frankenfield D, Furth S.
    J Am Soc Nephrol; 2006 Oct 13; 17(10):2878-85. PubMed ID: 16943308
    [Abstract] [Full Text] [Related]

  • 17. [Hypertension in hemodialysis patients in Andalucia].
    García Cortés MJ, Ceballos M, Grupo de tabajo sobre Calidad de la Hemodiálisis en Andalucía.
    Nefrologia; 2004 Oct 13; 24(2):149-57. PubMed ID: 15219090
    [Abstract] [Full Text] [Related]

  • 18. [Comorbidity, anemia and response to erythropoiesis stimulating agents in chronic hemodialysis].
    Anaya S, Rivera F, Sánchez de la Nieta MD, Carreño A, Vozmediano C, Alcaide MP, Arambarri M, Nieto J, Caparrós G, Ferreras I.
    Nefrologia; 2008 Oct 13; 28(2):186-92. PubMed ID: 18454709
    [Abstract] [Full Text] [Related]

  • 19. Is early treatment of anaemia with epoetin-alpha beneficial to pre-dialysis chronic kidney disease patients? Results of a multicentre, open-label, prospective, randomized, comparative group trial.
    Macdougall IC, Temple RM, Kwan JT.
    Nephrol Dial Transplant; 2007 Mar 13; 22(3):784-93. PubMed ID: 16968726
    [Abstract] [Full Text] [Related]

  • 20. Comparison of the therapeutic effects of epoetin zeta to epoetin alfa in the maintenance phase of renal anaemia treatment.
    Wizemann V, Rutkowski B, Baldamus C, Scigalla P, Koytchev R, Epoetin Zeta Study Group.
    Curr Med Res Opin; 2008 Mar 13; 24(3):625-37. PubMed ID: 18208642
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.